Terumo Corp 2020 IR
The report outlines Terumo Corporation's performance and strategic initiatives for fiscal year 2019, highlighting record-high revenue and adjusted operating profit despite the early impacts of the COVID-19 pandemic. It details the company's response to the pandemic, including maintaining a stable supply of medical devices and contributing to infection prevention. The report also covers strategies for its three in-house companies, corporate governance enhancements, and its commitment to sustainability and human rights.
Company: Terumo Corp
Sector: Manufacturing
Country: Japan
Year: 2020
Type: IR
Pages: 68
Back to company
Terumo Corp
Terumo Report
The report outlines Terumo Corporation's performance and strategic initiatives for fiscal year 2019, highlighting record-high revenue and adjusted operating profit despite the early impacts of the COVID-19 pandemic. It details the company's response to the pandemic, including maintaining a stable supply of medical devices and contributing to infection prevention. The report also covers strategies for its three in-house companies, corporate governance enhancements, and its commitment to sustainability and human rights.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2020
Fiscal Year
2019
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees